20 de abril de 2017 / 12:38 / en 7 meses

BRIEF-Immune Pharma signs LOI with Pint Pharma

April 20 (Reuters) - Immune Pharmaceuticals Inc

* Immune pharmaceuticals signs letter of intent with pint pharma regarding license and commercializion of ceplene® in latin america

* Immune pharmaceuticals -entered into a letter of intent with pint pharma gmnh, a pharmaceutical company focused on latin america and other markets Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below